Reducing Alcohol Use Among Patients with Hepatitis C

Area of Science:

• Hepatology
• Infectious Diseases
• Addiction Medicine

Background:

• Heavy alcohol use poses significant risks for individuals with chronic Hepatitis C Virus (HCV) infection.
• Co-infection with human immunodeficiency virus (HIV) and HCV exacerbates these risks, potentially leading to severe liver damage and mortality.
• These populations have historically received insufficient clinical attention regarding alcohol use management.

Purpose of the Study:

• To systematically review and synthesize existing literature on alcohol interventions for individuals with chronic HCV.
• To specifically examine interventions tailored for the HIV/HCV co-infected population.
• To build upon and update previous reviews on this topic.

Main Methods:

• A comprehensive literature search was conducted to identify relevant studies.
• Included studies evaluated the efficacy of drinking reduction interventions.
• Studies focused on populations with chronic HCV and those with HIV/HCV co-infection.

Main Results:

• Seven studies met the inclusion criteria: four for HCV and three for HIV/HCV co-infection.
• Participants showed significant positive responses to interventions.
• Key outcomes included increased abstinence rates, reduced alcohol consumption, fewer heavy drinking days, and enhanced treatment engagement.

Conclusions:

• Psychosocial interventions show promise in reducing alcohol use among individuals with chronic HCV and HIV/HCV co-infection.
• Successfully reducing alcohol intake is a critical behavioral change with positive implications for patient health.
• Further research and clinical attention are warranted for these vulnerable populations.